Share knowledge about health and disease exercise method weight loss tips for good health You can eat delicious food for a long time.
In addition to Sinovac and
slotxo Sinofarm, which are vaccines against COVID-19 from China, there is another interesting vaccine. and is a single needle injection No need to wait for the second injection like Sinovac and AstraZeneca are injecting in our home too.
Get to know the "Cancino" vaccine.
The CanSino vaccine is officially known as AD5-nCOV, or trade name. Convidecia, produced by Cancino Biologics, is a single-dose vaccine that is sufficient to build immunity.
Convidesia vaccine of the Company It is a vaccine produced using Adenovirus type 5 and is a viral vector vaccine that uses a weakened virus that does not cause disease. Let's edit and put the genetic material of the corona virus. to stimulate the body to build immunity
production technology Same as AstraZeneca Johnson & Johnson and Sputnik
Dr. Manoon Leechawengwong, a physician specializing in respiratory diseases Wichaiyut Hospital In a Facebook post, Dr. Manoon Leechawengwong FC stated that China's Kansas vaccine use new technology It deposits adenovirus type 5, a DNA virus that causes human diseases such as the common cold, sore throat, and conjunctivitis, to carry the genetic code (DNA) of the COVID-19 virus. Into the body to make the body immune to the protein thorns of the virus.
The cancino vaccine is given as a single dose. Like the Johnson & Johnson Company vaccine of the United States. And Russia's Sputnik doesn't have to give 2 doses like AstraZeneca. All four vaccines use the same technology. differ in the type of adenovirus
efficacy of the cancino vaccine
cancino vaccine It can be given to people aged 18 and over. Based on data from a phase 3 trial of 4,000 vaccinated people in Pakistan, Mexico, Russia, Chile and Argentina. cancino company Announcement of effective numbers for prevention of COVID-19 Of the vaccine on February 25, 63, it can increase protection against COVID-19 infection by 68.84% after 14 days of vaccination and decrease to 65.28% after 28 days of injection, but can prevent severe infections and Severe symptoms of COVID-19 were up to 95.47% after 14 days of injection and 90.07% after 28 days of injection, respectively.
Safety/Side Effects of Cancino Vaccine
Reuters Reported on April 14, 63 that the company's Kansas. Confirms that no dangerous side effects have been reported in people who have received the cancino vaccine. including thromboembolic problems
Countries that accept the Kansas vaccine
cancino vaccine It is currently approved for use in China, Pakistan, Mexico, Chile, Hungary and most recently Malaysia (updated June 15, 20) and is awaiting approval for registration by the WHO for emergency use.
A vaccine is being developed as an inhalation in the lungs.
In addition to injecting into the body through a syringe. The company cancino. The vaccine is also being adapted for inhalation into the lungs (see figure). It is in the final stages of study before it is approved for emergency use in China as the first country in the world. AstraZeneca Co. And companies in India are also studying the inhaled vaccine.
